XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 4,888,192 2,203,748 13,798,251 9,946,268
General and administrative 3,024,783 3,407,088 9,038,949 7,389,269
Stock-based compensation – general and administrative 1,003,677 373,570 2,929,279 993,114
Total Operating Expenses 8,916,652 5,984,406 25,766,479 18,328,651
Operating Loss (8,916,652) (5,984,406) (25,766,479) (18,328,651)
Other Income (Expense)        
Interest income 53,020 103,413 116,573 186,224
Other income 59,917 59,917
Interest expense (2,932) (10,839)
Total Other Income, Net 53,020 160,398 116,573 235,302
Net Loss (8,863,632) (5,824,008) (25,649,906) (18,093,349)
Deemed dividend on warrant extension 1,450,876 1,450,876
Net Loss Applicable to Common Stockholders $ (8,863,632) $ (7,274,884) $ (25,649,906) $ (19,544,225)
Net Loss Per Share Applicable to Common Stockholders - Basic (in Dollars per share) $ (0.06) $ (0.05) $ (0.18) $ (0.2)
Weighted Average Common Shares Outstanding        
Basic (in Shares) 146,129,630 137,151,269 146,061,108 96,002,039